Duque GA, Descoteaux A. Macrophage cytokines: involvement in immunity and infectious diseases. Front
Immunol. 2014;5:491. doi:10.3389/fimmu.2014.00491.
Alfaro C, Teijeira A, Oñate C, et al. Tumor-produced interleukin-8 attracts human myeloid-derived
suppressor cells and elicits extrusion of neutrophil extracellular traps (NETs). Clin Cancer Res.
2016;22(15):3924-3936.
Waugh DJJ, Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res. 2008;14(21):6735-6741.
David JM, Dominguez C, Hamilton DH, Palena C. The IL-8/IL-8R axis: a double agent in tumor immune
resistance. Vaccines (Basel). 2016;4(3). doi:10.3390/vaccines4030022.
Katanov C, Lerrer S, Liubomirski Y, et al. Regulation of the inflammatory profile of stromal cells in human
breast cancer: prominent roles for TNF-α and the NF-κB pathway. Stem Cell Res Ther. 2015;6:87.
doi:10.1186/s13287-015-0080-7.
Subramaniam KS, Tham ST, Mohamed Z, Woo YL, Adenan NAM, Chung I. Cancer-associated fibroblasts promote
proliferation of endometrial cancer cells. PLoS ONE. 2013;8(7):e68923. doi:10.1371/journal.pone.0068923.
Asfaha S, Dubeykovskiy AN, Tomita H, et al. Mice that express human interleukin-8 have increased
mobilization of immature myeloid cells, which exacerbates inflammation and accelerates colon carcinogenesis.
Gastroenterology. 2013;144(1):155-166.
Salmon H, Donnadieu E. Within tumors, interactions between T cells and tumor cells are impeded by the
extracellular matrix. Oncoimmunology. 2012;1(6):992-994.
Spiotto MT, Yu P, Rowley DA, et al. Increasing tumor antigen expression overcomes "ignorance" to solid
tumors via crosspresentation by bone marrow-derived stromal cells. Immunity. 2002;17(6):737-747.
Huang S, Mills L, Mian B, et al. Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit
angiogenesis, tumor growth, and metastasis of human melanoma. Am J Pathol. 2002;161(1):125-134.
Fujita Y, Okamoto M, Goda H, et al. Prognostic significance of interleukin-8 and CD163-positive
cell-infiltration in tumor tissues in patients with oral squamous cell carcinoma. PLoS ONE.
2014;9(12):e110378. doi:10.1371/journal.pone.0110378.
Sanmamed MF, Carranza-Rua O, Alfaro C, et al. Serum interleukin-8 reflects tumor burden and treatment
response across malignancies of multiple tissue origins. Clin Cancer Res. 2014;20(22):5697-5707.
Wu S, Shang H, Cui L, et al. Targeted blockade of interleukin-8 abrogates its promotion of cervical cancer
growth and metastasis. Mol Cell Biochem. 2013;375(1-2):69-79.